-
Neuronal Glycogen Breakdown in Tauopathy
2026-09-08
Bar and colleagues identify impaired neuronal glycogen metabolism as a conserved feature of tauopathy and show that enhancing glycogen breakdown improves disease-associated phenotypes in Drosophila and human iPSC-derived neurons. The study connects glycogen mobilization with pentose phosphate pathway activity and reduced oxidative stress, providing a mechanistic framework for interpreting metabolic interventions in neurodegeneration.
-
Ruxolitinib-Induced Apoptosis and Pyroptosis in ATC
2026-09-08
A 2024 Cell Death and Disease study identifies a mitochondrial mechanism by which ruxolitinib suppresses anaplastic thyroid carcinoma: JAK1/2-STAT3 inhibition reduces DRP1 transcription, disrupts mitochondrial fission, and promotes both caspase-dependent apoptosis and GSDME-mediated pyroptosis. The work provides a mechanistic rationale for studying JAK/STAT pathway modulation in ATC while highlighting the limits of translating preclinical findings directly to patients.
-
Biotin (Vitamin B7) for STING Assay Workflows
2026-09-07
Use Biotin (Vitamin B7) as a controlled avidin–streptavidin competition reagent, metabolic variable, and assay-quality control when adapting nucleic-acid sensing workflows. This guide separates what free biotin can do from covalent labeling chemistry, helping researchers build cleaner shrimp STING binding and antiviral-response assays.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-09-07
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or sticky ends.
-
RG7388 MDM2 Antagonist: Workflow Guide
2026-09-05
RG7388 enables mechanism-led studies of p53 reactivation, proliferation arrest, and apoptosis in wild-type p53 cancer models. This practical guide connects biochemical binding assays with cell-based, combination, and xenograft workflows while highlighting controls, formulation choices, and troubleshooting priorities.
-
Nitrocefin: Mapping β-Lactamase Function
2026-09-04
Nitrocefin is a chromogenic cephalosporin substrate that converts β-lactamase hydrolysis into a measurable color signal. This guide shows how to interpret that signal mechanistically, using the GOB-38 study to improve assay design, resistance profiling, and inhibitor screening.
-
Ginsenoside F1 Rewires Lipid Metabolism in HepG2 Cells
2026-09-04
The reference study combines free fatty acid-induced HepG2 modeling, biochemical lipid measurements, and untargeted lipidomics to show that ginsenoside F1 reduces intracellular lipid accumulation and alters glycerophospholipid-related metabolism. Its use of simvastatin as a positive control and its integration of network pharmacology and molecular docking provide a useful framework for interpreting lipid-regulatory mechanisms while highlighting the limits of cell-based translation.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-09-03
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY–Y1R pathway. The study connects adipose-derived signaling to NCX and CaMKII activity, while also identifying an important receptor distinction for future NPY-directed experiments.
-
VX-661 and the Proteostasis Logic of CFTR Rescue
2026-09-03
A translational framework for using VX-661 to connect F508del-CFTR trafficking, calnexin-dependent proteostasis, functional rescue, and variant-aware cystic fibrosis research.
-
NHS-Biotin for Multimeric Protein Workflows
2026-09-02
NHS-Biotin converts accessible lysines and N-terminal amines into stable biotin handles for detection, purification, and intracellular labeling. Its strongest value in multimeric nanobody workflows is analytical: it helps quantify and recover engineered assemblies without replacing the assembly mechanism itself.
-
Pregnancy, LNP Structure, and mRNA Delivery
2026-09-02
This PNAS study demonstrates that lipid nanoparticle chemistry and administration route jointly determine mRNA potency, inflammatory signaling, and maternal–fetal outcomes during pregnancy. Its mechanistic framework shows why formulation screening should evaluate placental cell targeting, maternal immune activation, and neonatal development rather than expression alone.
-
VX-661: F508del CFTR Corrector Workflow Guide
2026-09-01
Learn how to use VX-661 to separate CFTR trafficking rescue from channel potentiation in reproducible cell-based assays. This workflow combines practical dosing, orthogonal readouts, calnexin-aware variant testing, and troubleshooting for cystic fibrosis research.
-
Peptidisc-Assisted Nanobody Polybody Engineering
2026-09-01
A 2025 bioRxiv preprint introduces peptidisc-assisted hydrophobic clustering as a route to multimeric, bispecific, and autofluorescent nanobody assemblies. The resulting polybodies exploit avidity to improve binding performance while avoiding the need for conventional tandem linkers or large oligomerization scaffolds.
-
Prednisolone: Designing Interpretable GR Assays
2026-08-31
Prednisolone is a synthetic glucocorticoid for mechanistic glucocorticoid signaling research, inflammation modulation, and immunology research. This guide explains how to pair receptor-focused assays with ERAD studies without confusing transcriptional effects with targeted membrane-protein degradation.
-
N6-Methyl-dATP for Polymerase Assay Design
2026-08-31
N6-Methyl-dATP enables controlled analysis of methylated nucleotide recognition, DNA replication fidelity, and genomic stability. This article connects its biochemical use to assay decisions informed by the LMO2–LDB1 AML study, without conflating nucleotide chemistry with leukemia mechanism.